Management of Tardive Dyskinesia with Thiopropazate
Abstract
The author describes the successful management of two severe cases of tardive dyskinesia with thiopropazate. He concludes that the drug does have a place in the management of tardive dyskinesia even though its mechanism of action and long-range effects are unknown. He cautions, however, that it should be used only in severe cases.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
